Skip to main content
Download PDF

The PaO2/FiO2 is independently associated with 28-day mortality in patients with sepsis: a retrospective analysis from MIMIC-IV database

BMC Pulmonary Medicine volume 23, Article number: 187 (2023) Cite this article

Abstract

Background

To clarify the relationship between the PaO2/FiO2 and 28-day mortality in patients with sepsis.

Methods

This was a retrospective cohort study regarding MIMIC-IV database. Nineteen thousand two hundred thirty-three patients with sepsis were included in the final analysis. PaO2/FiO2 was exposure variable, 28-day mortality was outcome variable. PaO2/FiO2 was log-transformed as LnPaO2/FiO2. Binary logistic regression was used to explore the independent effects of LnPaO2/FiO2 on 28-day mortality using non-adjusted and multivariate-adjusted models. A generalized additive model (GAM) and smoothed curve fitting was used to investigate the non-linear relationship between LnPaO2/FiO2 and 28-day mortality. A two-piecewise linear model was used to calculate the OR and 95% CI on either side of the inflection point.

Results

The relationship between LnPaO2/FiO2 and risk of 28-day death in sepsis patients was U-shape. The inflection point of LnPaO2/FiO2 was 5.30 (95%CI: 5.21—5.39), which indicated the inflection point of PaO2/FiO2 was 200.33 mmHg (95%CI: 183.09 mmHg—219.20 mmHg). On the left of inflection point, LnPaO2/FiO2 was negatively correlated with 28-day mortality (OR: 0.37, 95%CI: 0.32—0.43, p < 0.0001). On the right of inflection point, LnPaO2/FiO2 was positively correlated with 28-day mortality in patients with sepsis (OR: 1.53, 95%CI: 1.31—1.80, p < 0.0001).

Conclusions

In patients with sepsis, either a high or low PaO2/FiO2 was associated with an increased risk of 28-day mortality. In the range of 183.09 mmHg to 219.20 mmHg, PaO2/FiO2 was associated with a lower risk of 28-day death in patients with sepsis.

Peer Review reports

Introduction

Sepsis is defined as a potentially fatal organ dysfunction caused by dysregulated host response to infection [1]. In 2017, an estimated 489 million incident cases of sepsis were recorded worldwide, with 110 million sepsis-related deaths reported, accounting for 19.7% of global mortality [2]. Furthermore, sepsis has become the leading cause of intensive care unit (ICU) admission and in-hospital death [2,3,4]. Early identification and appropriate management of sepsis may improve patient survival outcomes [1]. To find out the possible cause of death of septic patients may be important for sepsis management.

Recently, the arterial partial pressure of oxygen (PaO2) has attracted much attention. As we know, low PaO2 is associated with high mortality in critically ill patients [5, 6]. However, although higher PaO2 levels may improve the oxygen delivery, they can also lead to potential harm such as the tissue injury. To correct the effect of FiO2 on the PaO2, the ratio of arterial partial pressure of oxygen (PaO2) to fraction of inspired oxygen (FiO2) is usually used. PaO2/FiO2 is important for the diagnosis of sepsis as one of the variables in sequential organ failure assessment (SOFA) score [7, 8]. A retrospective study of 135 elderly patients with sepsis showed that PaO2/FiO2 was a promising tool and biomarker for predicting 28-day mortality [9]. High PaO2/FiO2 was an independent risk factor for 28-day mortality in patients with sepsis-related myocardial injury [10]. In addition, a novel blended machine learning (ML) model for hospital mortality prediction in ICU patients with sepsis identified the minimum PaO2/FiO2 as one of the top important predictors [11]. However, novel machine learning techniques are time-consuming to implement in practice, and are inapplicable to clinical work. Additional concerns are also raised about the clinical utility of results from studies with small sample sizes, population limitations, and failure to consider the possibility of non-linear relationships. More importantly, it is still unknown which range of PaO2 was appropriate in patients with sepsis.

We hypothesized that an abnormal PaO2/FiO2 was associated with a high risk of 28-day mortality in patients with sepsis. Therefore, we aimed to investigate the relationship between the PaO2/FiO2 and 28-day mortality in patients with sepsis using a large-scale database.

Methods

Data source

This was a retrospective analysis based on the Medical Information Marketplace for Intensive Care IV (MIMIC-IV) database. It gathered clinical data on patients who admitted to Beth Israel Deaconess Medical Center (BIDMC) from 2008 to 2019 [12]. The database is free to download after completing an accredited course on their official website. One of the authors, Lu Chen, has completed the accredited course and was responsible for data extraction (Record ID: 50,668,217). Our study was performed in accordance with the reports of studies conducted using the observation routine collected health data (RECORD) [13].

Study population

In total, 377, 207 adult patient records were found in the MIMIC-IV database. Sepsis was diagnosed according to sepsis-3 criteria [1], sepsis-relevant ICD-9 codes (99,591—99,592), or ICD-10 codes (R652, R6520 and R6521) [14, 15]. The outcome variable was death from any cause during 28-day after ICU admission, and PaO2/FiO2 was the exposure variable (recorded as a continuous variable). We extracted PaO2/FiO2 data at ICU admission. Patients with missing exposure variable information were excluded from this study. We collected demographic factors such as gender (male / female), age (years), ethnicity, Charlson Comorbidity Index, SOFA score, use of mechanical ventilation and renal replacement therapy (RRT), use of glucocorticoids (dexamethasone, methylprednisolone, cortisol), use of vasoactive drugs (dopamine, dobutamine, noradrenaline), use of intravenous immunoglobulin (IVIG), use of antibiotics (carbapenem, cephalosporins, penicillin, vancomycin), vital signs on admission include temperature, heart rate, respiratory rate and mean arterial pressure as main covariates. The selection of these covariates was primarily based on our clinical experience as well as literature [16,17,18,19].

Missing data description

Patients with missing exposure and outcome information were removed. The missing covariates in this study were less than 5% (0—4.1%), therefore, multiple interpolation was not used to fill in the gaps.

Statistical analysis

Continuous variables were expressed as mean ± standard deviation (normal distribution) or median (quartile) (skewed distribution). Categorical variables were expressed in frequency or as a percentage. Since this was a cohort study, we divided the exposure variables into four quartiles, the distribution of patient baseline characteristics differed across quartiles. The one-way ANOVA (normal distribution), Kruskal–Wallis H (skewed distribution) test and chi-square tests (categorical variables) was used to determine any statistical difference among the means and proportions of the groups. Univariate binary logistic regression model was used to evaluate the associations between exposure and outcome. Both non-adjusted and multivariate-adjusted models were used. We explored the association between PaO2/FiO2 and 28-day mortality using univariate and multivariable binary logistic regression models. We log-transformed PaO2/FiO2 to LnPaO2/FiO2, due to its skewed distribution. During the data analysis, we present non-adjusted models (no covariates adjusted), minimally-adjusted models (adjusted for demographic factors only, Model I), fully-adjusted models (adjusted for all covariates presented in Table 1, Model II), and odds ratio values (OR) with 95% confidence intervals (CI). LnPaO2/FiO2 was transformed from a continuous variable to a categorical variable (quartile) for sensitivity analysis, and P for trend was calculated to see if the results were robust when LnPaO2/FiO2 was used as a continuous variable versus a categorical variable. Furthermore, we used Hosmer–Lemeshow Test to assess the goodness of fit of the above three models (non-adjusted, adjusted model I and adjusted model II) and reported Chi-square and P values (using R ResourceSelection-package and Hoslem. test Function). A non-linear relationship cannot be ruled out because LnPaO2/FiO2 is a continuous variable. Given the binary logistic regression model’s inability to handle non-linear associations, we observed the relationship between LnPaO2/FiO2 and 28-day mortality in patients with sepsis using a generalized additive model (GAM) and smoothed curve fitting. If there was a non-linear correlation, we used a recursive algorithm to calculate the inflection point value and 95% confidence interval (bootstrapping), and used a two-piecewise linear model to calculate the OR and 95% CI on either side of the inflection point. All the analyses were performed with the statistical software packages R (http://www.R-project.org, The R Foundation) and EmpowerStats (http://www.Empowerstats.com, X&Y Solutions, Inc, Boston, MA). P values less than 0.05 (two-sided) were considered statistically significant.

Table 1 Baseline characteristics of patients according to LnPaO2/FiO2 (N = 19, 233)
Full size table

Result

Patient screening process description

A total of 377, 207 cases from the MIMIC-IV database were enrolled in the study. There were 342, 297 non-septic patients and 15, 777 patients with missing PaO2/FiO2 information. Therefore, 19, 233 cases were included in the final analysis. The patient selection flow chart is shown in Fig. 1.

Fig. 1
figure 1

Flow chart. MIMIC: Medical Information Mart for Intensive Care

Full size image

Baseline characteristics of patients

The baseline characteristics of patients are listed in Table 1. Based on the quartile grouping, LnPaO2/FiO2 of the overall population was equally divided into four groups (Q1 to Q4). Then the characteristics of the distribution of each variable in each group were analyzed. The mean age of patients was 65.57 ± 15.65 years. The 28-day mortality rate in patients with sepsis was 19.13% (3678/19, 233). The distribution of cephalosporin antibiotic did not differ statistically significantly in different LnPaO2/FiO2 subgroups (p = 0.088). Compared with high-level (Q4) of LnPaO2/FiO2 group, patients had higher age, higher Charlson Comorbidity Index, SOFA scores, body temperatures, respiratory and heart rate, higher FiO2, and had greater percentages of using RRT, dopamine, dobutamine, noradrenaline, methylprednisolone, cortisone, intravenous immunoglobulin, carbapenem, penicillin, and vancomycin antibiotics in other three groups (Q1 ~ Q3). In contrast, higher MAP and PaO2, lower rates of using dexamethasone and mechanical ventilation in Q4 group was observed compared with other three groups (Q1 ~ Q3).

The relationship between LnPaO2/FiO2 and 28-day mortality in patients with sepsis using non-adjusted and adjusted models

Different covariate adjustment strategies were used to enlighten the association between LnPaO2/FiO2 and 28-day mortality in patients with sepsis. The non-adjusted and adjusted models are shown in Table 2. In non-adjusted model, for each 1 increase in LnPaO2/FiO2, the risk of 28-day death in patients with sepsis was decreased by 51% (OR: 0.49, 95%CI: 0.46—0.52). In adjusted I model (sex, age at admission and ethnicity were adjusted), the trend of OR did not to be altered (OR: 0.49, 95%CI: 0.46—0.52, p < 0.001). In adjusted II model (sex, age at admission, ethnicity, Charlson Comorbidity Index, SOFA scores, the use of dexamethasone, methylprednisolone, cortisone, noradrenaline, dopamine, dobutamine, IVIG, the use of mechanical ventilation and RRT, the use of carbapenem, cephalosporins, penicillin, vancomycin, heart rate, respiratory rate, temperature and MAP were adjusted), the risk of 28-day death was decreased by 28% (OR: 0.72, 95%CI: 0.67—0.79, p < 0.001). For sensitivity analysis, we also handled LnPaO2/FiO2 as a categorical variable (Quartile). The same trend was observed as well (p for trend was 0.0005). The Hosmer–Lemeshow Test shown that the three models were not a good fit and further fitting with the GAM model was required.

Table 2 Relationship between LnPaO2/FiO2 and 28-day mortality in patients with sepsis
Full size table

Non-linear relationship between LnPaO2/FiO2 and 28-day mortality in patients with sepsis

We explored the non-linear relationship between LnPaO2/FiO2 and 28-day mortality in patients with sepsis using generalized additive model and smoothed curve fitting. We found that the relationship between LnPaO2/FiO2 and 28-day mortality in patients with sepsis was U-shape (sex, age at admission, ethnicity, Charlson Comorbidity Index, SOFA scores, the use of dexamethasone, methylprednisolone, cortisone, noradrenaline, dopamine, dobutamine, IVIG, the use of mechanical ventilation and RRT, the use of carbapenem, cephalosporins, penicillin, vancomycin, heart rate, respiratory rate, temperature and MAP were adjusted). For ease of comprehension of the results, calculated after conversion, the non-linear relationship between PaO2/FiO2 and 28-day mortality in patients with sepsis is shown in Fig. 2. By two-piecewise linear regression model and recursive algorithms, the inflection point of LnPaO2/FiO2 was 5.30 (95%CI: 5.21—5.39). Calculated after conversion, i.e., the inflection point of PaO2/FiO2 was 200.33 mmHg (95%CI: 183.09—219.20 mmHg). On the left of inflection point, for each 1 increase in LnPaO2/FiO2 (or a 2.72 mmHg increases in PaO2/FiO2), the risk of sepsis 28-day death was decreased by 63% (OR: 0.37, 95%CI: 0.32—0.43, p < 0.0001). On the right of inflection point, for each 1 increase in LnPaO2/FiO2, the risk of sepsis 28-day death was increased 53% (OR: 1.53, 95%CI: 1.31—1.80, p < 0.0001) (Table 3).

Fig. 2
figure 2

The non-linear relationship between PaO2/FiO2 and 28-day mortality in patients with sepsis

Full size image
Table 3 Threshold effect analysis for the relationship between LnPaO2/FiO2 and 28-day mortality in patients with sepsis
Full size table

Discussion

Based on 19, 233 sepsis patients in the MIMIC-IV database, this large retrospective study found that the PaO2/FiO2 was independently associated with a 28-day mortality in patients with sepsis. After covariate adjustment strategies and sensitivity analysis, a U-shape relationship between PaO2/FiO2 and 28-day mortality was revealed. The results indicated that either a high or low PaO2/FiO2 was associated with an increased risk of death in sepsis patients. Moreover, we found that PaO2/FiO2 between 183.09 mmHg and 219.20 mmHg was associated with a lower risk of 28-day death in patients with sepsis.

As mentioned before, PaO2/FiO2 as one of items in SOFA score could reflect the severity of illness. Some studies have shown that PaO2/FiO2 was an independent risk factor for 28-day death in patients with sepsis [9, 10, 20], which was also confirmed our study. However, there was a U-shape relationship between PaO2/FiO2 and 28-day mortality in patients with sepsis through analysis using generalized additive model and smoothed curve fitting.

Apart from FiO2 values, it was also a U-shaped association between PaO2 during the first 24 h after ICU admission in mechanically ventilated patient [21]. As we know, sepsis is a major disease in ICU. A retrospective study conducted by Zhongheng Zhang and colleagues, which used data from the MIMIC-II database and included 11, 002 ICU patients, showed that the relationship between PaO2 levels and mortality in sepsis patients was quadratic and non-linear [22]. PaO2 is usually affected by FiO2, therefore we used PaO2/FiO2 to explore the association between hypoxaemia and 28-day mortality. These studies indicate that patients with either a very low or high PO2 have a higher mortality rate. Low PaO2 in patients means hypoxaemia, which related to anaerobic metabolism, cellular dysfunction, and progressive metabolic lactic acidosis. High PO2 in patients is not good either, which leads to pulmonary toxicity, augmented ischemia–reperfusion injury, and systemic vasoconstriction with decreased organ perfusion [23, 24]. In this study, we used the updated MIMIC database, and the exposure variables were composite indicators and more abundant. The adjustment strategy was focused on adjusting treatment (such as the use of dexamethasone, methylprednisolone, cortisone, the use of noradrenaline, dopamine, dobutamine, IVIG, the use of mechanical ventilation and RRT, the use of carbapenem, cephalosporins, penicillin, vancomycin).

In addition, we found that PaO2/FiO2 in the range of 183.09 mmHg to 219.20 mmHg, was associated with a lower risk of death in patients with sepsis. This result is consistent with a previous study conducted by Peng et al. The study also used the MIMIC-IV database. Machine learning was used to identify sepsis subphenotypes and compare the clinical outcomes for subphenotypes. The PaO2/FiO2 in subphenotype A and B were 202 (130—285) mmHg vs 113 (74—183) mmHg respectively (p < 0.001) [25]. Mean PaO2/FiO2 for subphenotype A patients similar our threshold period. The researchers found that the hospital mortality in participants with subphenotype B was higher than subphenotype A. Why does a higher PaO2/FiO2 increase patient mortality? This might be attributable to the fact that the relation of the PaO2/FiO2 as a function of the FiO2 is non-linear and can be U-shaped depending on the underlying shunt fraction and the arterial-mixed venous oxygen content function [26]. Consequently, the PaO2/FiO2 can increase sharply at very high FiO2. Sustained exposure to FiO2 of 0.7 or greater was toxic across numerous species. HYPERS2S trail showed setting FiO2 to 1.0 to induce arterial hyperoxia might increase the risk of mortality in patients with septic shock [27]. This is mainly related to excessive production of reactive oxygen species (ROS) [23].

Strengths and limitations

Firstly, the large sample size provides us with more reliable results, allowing us to better understand the association between PaO2/FiO2 and 28-day mortality in patients with sepsis. Secondly, sensitivity analysis and non-linear algorithm used in this study can help us better observe and address the association between PaO2/FiO2 and 28-day mortality in patients with sepsis. However, this study has the following limitations. Firstly, the study's population was primarily from the United States, so additional clinical studies were required to determine whether the findings can be applied to populations from other countries. Secondly, as this was an observational study, confounding could not be avoided. Although, we rigorously adjusted for confounding and used sensitivity analysis to assess the robustness of the results. Thirdly, due to the limitations of observational studies, we can only observe associations and cannot assess cause and effect. Fourthly, although there were some antibiotics were chosen as variables, some may still be ignored. Fifthly, considering the logistic regression fit was powerless, the binary logistic regression results should be regarded with caution. Lastly, we could only adjust for measurable confounding, not non-measurable confounding, implying that larger population clinical studies with higher levels of evidence may be required to validate our findings.

Conclusion

There was a U-shaped relationship between PaO2/FiO2 and 28-day mortality in patients with sepsis. In the range of 184.93 mmHg to 219.20 mmHg, PaO2/FiO2 was associated with a lower risk of death in patients with sepsis. This finding indicates that we should pay more attention to PaO2/FiO2 levels in clinical work.

Availability of data and materials

The datasets analyse during the current study are available in the MIMIC-IV repository, https://physionet.org/content/mimiciv/0.4/. The links is the direct persistent links to the datasets and researchers need to completed the course Protecting Human Research Participants on the website of National Institutes of Health and obtained the certification prior to accession. The data can be accessed from the corresponding author Xu Liu, e-mail: 262347762@qq.com.

Abbreviations

ICU:

Intensive care unit

ARDS:

Acute respiratory distress syndrome

SOFA:

Sequential Organ Failure Assessment

ML:

Machine learning

MIMIC-IV:

Medical information marketplace for intensive care IV

GAM:

Generalized additive mode

IVIG:

Intravenous immunoglobulin

MV:

Mechanical ventilation

OR:

Odds ratio

CI:

Confidence interval

Ref:

Reference

MAP:

Mean arterial pressure

RRT:

Renal replacement therapy

References

  1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–11.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Fleischmann-Struzek C, Mellhammar L, Rose N, Cassini A, Rudd KE, Schlattmann P, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–247.

    Article  PubMed  PubMed Central  Google Scholar 

  5. SRLF Trial Group. Hypoxemia in the ICU: prevalence, treatment, and outcome. Ann Intensive Care. 2018;8(1):82.

    Article  Google Scholar 

  6. de Jonge E, Peelen L, Keijzers PJ, et al. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Critical Care. 2008;12(6, article R156):1–8.

    Article  Google Scholar 

  7. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):775–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):374.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Li T, Hu WQ, Li X, Zhang JP, Tan LZ, Yu LX, et al. Prognostic value of PaO2/FiO2, SOFA and D-dimer in elderly patients with sepsis. J Int Med Res. 2022;50(6):3000605221100755.

    Article  CAS  PubMed  Google Scholar 

  10. Zhang M, Duan M, Zhi D, Lin J, Liu P, Wang Y. Risk factors for 28-day mortality in patients with sepsis-related myocardial injury in intensive care units. J Int Med Res. 2021;49(4):3000605211004759.

    Article  PubMed  Google Scholar 

  11. Zeng Z, Yao S, Zheng J, Gong X. Development and validation of a novel blending machine learning model for hospital mortality prediction in ICU patients with Sepsis. BioData Min. 2021;14(1):40.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Johnson AE, Pollard TJ, Shen L, Lehman LW, Feng M, Ghassemi M, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;24(3): 160035.

    Article  Google Scholar 

  13. Langan SM, Schmidt SA, Wing K, Ehrenstein V, Nicholls SG, Filion KB, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018;14(363):k3532.

    Article  Google Scholar 

  14. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–54.

    Article  PubMed  Google Scholar 

  15. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–10.

    Article  CAS  PubMed  Google Scholar 

  16. Roggeveen LF, Guo T, Fleuren LM, Driessen R, Thoral P, van Hest RM, et al. Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial. Crit Care. 2022;26(1):265.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Cao B, Chen Q, Tang T, Li H, Zhong X, Hao P, et al. Non-linear relationship between baseline mean arterial pressure and 30-day mortality in patients with sepsis: a retrospective cohort study based on the MIMIC-III database. Ann Transl Med. 2022;10(16):872.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Luo M, Chen Y, Cheng Y, Li N, Qing H. Association between hematocrit and the 30-day mortality of patients with sepsis: a retrospective analysis based on the large-scale clinical database MIMIC-IV. PLoS one. 2022;17(3):e0265758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Li S, Hu X, Xu J, Huang F, Guo Z, Tong L, et al. Increased body mass index linked to greater short- and long-term survival in sepsis patients: a retrospective analysis of a large clinical database. Int J Infect Dis. 2019;87:109–16.

    Article  PubMed  Google Scholar 

  20. Wang S, Li T, Li Y, Zhang J, Dai X. Predictive value of four different scoring systems for septic patient’s outcome: a retrospective analysis with 311 patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017;29(2):133–8.

    PubMed  Google Scholar 

  21. de Jonge E, Peelen L, Keijzers PJ, et al. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care. 2008;12(6):R156.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Zhang Z, Ji X. Quadratic function between arterial partial oxygen pressure and mortality risk in sepsis patients: an interaction with simplified acute physiology score. Sci Rep. 2016;13(6):35133.

    Article  Google Scholar 

  23. Singer M, Young PJ, Laffey JG, Asfar P, Taccone FS, Skrifvars MB, Meyhoff CS, Radermacher P. Dangers of hyperoxia. Crit Care. 2021;25(1):440.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Vincent JL, Taccone FS, He X. Harmful effects of hyperoxia in postcardiac arrest, sepsis, traumatic brain injury, or stroke: the importance of individualized oxygen therapy in critically Ill patients. Can Respir J. 2017;2017:2834956.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Hu C, Li Y, Wang F, Peng Z. Application of machine learning for clinical subphenotype identification in sepsis. Infect Dis Ther. 2022;11:1949–64.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Aboab J, Louis B, Jonson B, Brochard L. Relation between PaO2/FIO2 ratio and FIO2: a mathematical description. Intensive Care Med. 2006;32(10):1494–7.

    Article  PubMed  Google Scholar 

  27. Asfar P, Schortgen F, Boisramé-Helms J, et al. Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial [published correction appears in Lancet Respir Med. 2017 Aug;5(8): e28]. Lancet Respir Med. 2017;5(3):180–90.

    Article  CAS  PubMed  Google Scholar 

  28. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.

    Article  Google Scholar 

Download references

Acknowledgements

None.

Funding

This study was supported by National Key Research and Development Plan of China (2018YFC2001904); National Natural Science Foundation of China (81960357, 81701958); Guizhou Provincial Science and Technology Projects (Qian Ke He Jichu [2020]1Y330, Qian Ke He Jichu-ZK [2022] Yiban 370), the Special Fund of Wu Jieping Medical Foundation for Clinical Scientific Research (320.6750.18001).

Author information

Authors and Affiliations

  1. Department of Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

    Hongying Bi, Xu Liu, Xian Liu & Yan Tang

  2. Department of Immunology and Microbiology, Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, China

    Chi Chen

  3. Clinical Trials Centre, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

    Lu Chen

  4. Guizhou Medical University, Guiyang, Guizhou, China

    Jianmin Zhong

Authors
  1. Hongying Bi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chi Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xian Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jianmin Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yan Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Hongying Bi: Methodology, analyzed data, writing - original draft, writing - review and editing; Xu Liu: Revised the paper, supervision, funding acquisition; Chi Chen and Lu Chen: Software, extracts the database, formal analysis; Jianmin Zhong: Formal analysis, writing - review and editing; Xian Liu: Prepared Figs. 1 and 2, revised the paper; Yan Tang: Supervision, revised the paper. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xu Liu.

Ethics declarations

Ethics approval and consent to participate

This study made use of the MIMIC-IV database. The database was approved by the Institutional Review Boards of Beth Israel Deaconess Medical Center in Boston, Massachusetts, and the Massachusetts Institute of Technology. This was a retrospective analysis, and the databases do not contain protected health information. Therefore, the Institutional Review Boards of the Affiliated Hospital of Guizhou Medical University waived the ethical approval statement and the need for informed consent. All methods in this study were carried out in accordance with relevant guidelines and regulations (the Declarations of Helsinki) [28].

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bi, H., Liu, X., Chen, C. et al. The PaO2/FiO2 is independently associated with 28-day mortality in patients with sepsis: a retrospective analysis from MIMIC-IV database. BMC Pulm Med 23, 187 (2023). https://doi.org/10.1186/s12890-023-02491-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12890-023-02491-8

Keywords

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us